BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 28,700 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of C$3.82, for a total value of C$109,634.00. Following the transaction, the director directly owned 362,370 shares of the company’s stock, valued at approximately C$1,384,253.40. This trade represents a 7.34% decrease in their position.
Derek Webb also recently made the following trade(s):
- On Thursday, August 20th, Derek Webb sold 15,000 shares of BioRem stock. The stock was sold at an average price of C$3.82, for a total transaction of C$57,300.00.
BioRem Trading Up 0.3%
Shares of CVE BRM opened at C$3.64 on Friday. The firm’s 50 day moving average price is C$3.34 and its 200-day moving average price is C$3.02. BioRem Inc. has a 52-week low of C$1.87 and a 52-week high of C$3.95. The company has a debt-to-equity ratio of 14.17, a quick ratio of 1.08 and a current ratio of 2.04. The company has a market cap of C$58.67 million, a PE ratio of 10.83 and a beta of 0.81.
About BioRem
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems.
Further Reading
- Five stocks we like better than BioRem
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
